Search Results 101-110 of 19773 for CLL
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or R/R SLL pretreated with ...
-
A Study Of APG-2575 Alone Or In Combination With Other Therapeutic Agents To Treat Relapsed And/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
... CLL Patients. ASCO Abstract Number: 6522 An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...